Efficacy of Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis With Severe Itch at Baseline and in Subgroups by Baseline Thresholds of Severe Itch: A Post Hoc Analysis of the JADE COMPARE and JADE DARE Clinical Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 2, p. s380, 2024. DOI: 10.25251/skin.8.supp.380. Disponível em: https://skin.dermsquared.com/skin/article/view/2691. Acesso em: 19 may. 2025.